Want to see AU:C79 full AI Analyst Report?
C79 Stock Chart & Stats
AU$7.40
AU$0.09(1.63%)
At close: 4:00 PM EDT
AU$7.40
AU$0.09(1.63%)
Day’s Range― - ―
52-Week RangeAU$5.18 - AU$10.13
Previous CloseN/A
Volume106.70K
Average Volume (3M)263.23K
Market Cap
AU$738.92M
Enterprise ValueAU$720.88
Total Cash (Recent Filing)AU$25.89M
Total Debt (Recent Filing)AU$64.33M
Price to Earnings (P/E)417.5
Beta1.55
Next Earnings
Feb 24, 2027EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding116,733,795
10 Day Avg. Volume165,899
30 Day Avg. Volume263,232
Financial Highlights & Ratios
PEG Ratio-3.10
Price to Book (P/B)3.42
Price to Sales (P/S)6094.99
P/FCF Ratio-26.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$8.85Price Target Upside19.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.05
Revenue Forecast (FY)AU$112.61M
Bulls Say, Bears Say
Bulls Say
Recurring PhotonAssay Service RevenueThe service-based model can create recurring revenue from installed PhotonAssay units, usage, support, maintenance, and consumables. As deployments and sample volumes expand, this installed-base revenue may improve visibility and reduce reliance on one-off equipment sales over the medium term.
Equity-supported Balance SheetA substantial equity base and moderate leverage provide financial flexibility to support commercialization and absorb operating volatility. Balance-sheet expansion since 2021 gives Chrysos more capacity to fund deployments and manage near-term execution demands than a highly leveraged structure would allow.
Improving Operating Cash FlowPositive and improving operating cash flow indicates that the core business is generating cash before investment spending, an important foundation for scaling the technology. Continued improvement could reduce dependence on external funding if investment requirements and operating execution remain controlled.
Bears Say
Revenue ContractionThe sharp 2026 revenue decline interrupts the prior growth trajectory and raises questions about the pace of customer adoption, unit deployment, or utilization. Sustained contraction would weaken operating leverage, reduce resources available for investment, and make the growth profile less predictable over the next several quarters.
Severe Profitability DeteriorationThe move from strong gross profit in 2024–2025 to deeply negative gross profit and operating losses in 2026 signals substantial pressure on the economics of the business. If this persists, it could limit self-funded growth and undermine confidence that installed-unit expansion will translate into durable earnings.
Persistent Free Cash Flow BurnConsistently negative free cash flow means investment spending continues to exceed internally generated cash, even when reported net income is positive. Persistent cash burn can create ongoing funding needs, constrain capital allocation, and increase execution risk while Chrysos expands its installed technology base.
Chrysos Corp. Ltd. News
C79 FAQ
What was Chrysos Corp. Ltd.’s price range in the past 12 months?
Chrysos Corp. Ltd. lowest share price was AU$5.18 and its highest was AU$10.13 in the past 12 months.
What is Chrysos Corp. Ltd.’s market cap?
Chrysos Corp. Ltd.’s market cap is AU$738.92M.
When is Chrysos Corp. Ltd.’s upcoming earnings report date?
Chrysos Corp. Ltd.’s upcoming earnings report date is Feb 24, 2027 which is in 148 days.
How were Chrysos Corp. Ltd.’s earnings last quarter?
Chrysos Corp. Ltd. released its earnings results on Aug 10, 2026. The company reported AU$0.009 earnings per share for the quarter, beating the consensus estimate of AU$0.006 by AU$0.003.
Is Chrysos Corp. Ltd. overvalued?
According to Wall Street analysts Chrysos Corp. Ltd.’s price is currently Undervalued.
Does Chrysos Corp. Ltd. pay dividends?
Chrysos Corp. Ltd. does not currently pay dividends.
What is Chrysos Corp. Ltd.’s EPS estimate?
Chrysos Corp. Ltd.’s EPS estimate is 0.03.
How many shares outstanding does Chrysos Corp. Ltd. have?
Chrysos Corp. Ltd. has 116,733,795 shares outstanding.
What happened to Chrysos Corp. Ltd.’s price movement after its last earnings report?
Chrysos Corp. Ltd. reported an EPS of AU$0.009 in its last earnings report, beating expectations of AU$0.006. Following the earnings report the stock price went up 17.209%.
Which hedge fund is a major shareholder of Chrysos Corp. Ltd.?
Currently, no hedge funds are holding shares in AU:C79
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chrysos Corp. Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$8.85 (19.59% Upside)
AU$8.85 (19.59% Upside)
Insider Transactions
Sold Shares
Worth AU$3.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.88%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
15.95%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Chrysos Corp. Ltd.
Chrysos Corporation Limited is dedicated to creating and delivering advanced solutions for the mining industry. Established in 2016 and based in Adelaide, Australia, the company's flagship product is PhotonAssay. This innovative technology enables the accurate and efficient analysis of elements such as gold, silver, and copper, among others.
C79 Stock 12 Month Forecast
Average Price Target
AU$8.85
▲(19.59% Upside)
Technical Analysis
Pointerra
―
Aerometrex Ltd.
―
Vection Technologies Ltd.
―
UUV Aquabotix Ltd.
―
Nuix Ltd.
―







